NasdaqGS - Delayed Quote • USD
Halozyme Therapeutics, Inc. (HALO)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 7:49 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
---|---|---|---|
BIZZARI JEAN-PIERRE Director | Stock Award(Grant) | May 5, 2023 | 66,815 |
DALY JAMES M. Director | Sale | Aug 14, 2023 | 20,503 |
DUNCAN BARBARA GAYLE Director | Stock Award(Grant) | May 5, 2023 | 9,253 |
HENDERSON JEFFREY WILLIAM Director | Stock Award(Grant) | May 5, 2023 | 47,110 |
LABARRE MICHAEL J. Chief Technology Officer | Sale | Apr 17, 2024 | 168,176 |
LABROSSE NICOLE Chief Financial Officer | Conversion of Exercise of derivative security | Feb 16, 2024 | 15,480 |
MATSUI CONNIE L Director | Stock Award(Grant) | May 5, 2023 | 187,004 |
POSARD MATTHEW L Director | Stock Award(Grant) | May 5, 2023 | 113,254 |
SNYDER MARK HOWARD General Counsel | Conversion of Exercise of derivative security | Feb 16, 2024 | 11,680 |
TORLEY HELEN I Chief Executive Officer | Conversion of Exercise of derivative security | Feb 16, 2024 | 676,744 |
Related Tickers
GMAB Genmab A/S
28.15
+2.51%
IONS Ionis Pharmaceuticals, Inc.
41.59
-0.60%
UTHR United Therapeutics Corporation
233.85
-0.89%
EXEL Exelixis, Inc.
23.70
+0.72%
BPMC Blueprint Medicines Corporation
93.00
+2.50%
FOLD Amicus Therapeutics, Inc.
10.28
+1.08%
INCY Incyte Corporation
51.68
+0.98%
RARE Ultragenyx Pharmaceutical Inc.
44.24
+0.89%
LEGN Legend Biotech Corporation
45.30
+1.98%
JAZZ Jazz Pharmaceuticals plc
109.46
+1.89%